Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf P Obermayr

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Wiener Medizinische Wochenschrift (1946)|March 9, 2004
[Perspectives on treatment of hypertension in elderly patients]Rudolf P Obermayr, Karl Heinz Tragl
Gerontology|April 8, 2003
The reduced release of GH by GHRH in 8 subjects aged 65-69 years is augmented considerably by rivastigmine, a drug for Alzheimer's diseaseRudolf P Obermayr, Lothar Mayerhofer, Maarten Knechtelsdorfer, et al.
Journal of the American Society of Nephrology : JASN|September 19, 2008
Elevated uric acid increases the risk for kidney diseaseRudolf P Obermayr, Christian Temml, Georg Gutjahr, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 27, 2009
Body mass index modifies the risk of cardiovascular death in proteinuric chronic kidney diseaseRudolf P Obermayr, Christian Temml, Georg Gutjahr, et al.
Experimental Gerontology|March 15, 2005
The age-related down-regulation of the growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer's diseaseRudolf P Obermayr, Lothar Mayerhofer, Maarten Knechtelsdorfer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2007
Predictors of new-onset decline in kidney function in a general middle-european populationRudolf P Obermayr, Christian Temml, Maarten Knechtelsdorfer, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Wiener Medizinische Wochenschrift (1946)|March 9, 2004
[Perspectives on treatment of hypertension in elderly patients]Rudolf P Obermayr, Karl Heinz Tragl
Gerontology|April 8, 2003
The reduced release of GH by GHRH in 8 subjects aged 65-69 years is augmented considerably by rivastigmine, a drug for Alzheimer's diseaseRudolf P Obermayr, Lothar Mayerhofer, Maarten Knechtelsdorfer, et al.
Journal of the American Society of Nephrology : JASN|September 19, 2008
Elevated uric acid increases the risk for kidney diseaseRudolf P Obermayr, Christian Temml, Georg Gutjahr, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 27, 2009
Body mass index modifies the risk of cardiovascular death in proteinuric chronic kidney diseaseRudolf P Obermayr, Christian Temml, Georg Gutjahr, et al.
Experimental Gerontology|March 15, 2005
The age-related down-regulation of the growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer's diseaseRudolf P Obermayr, Lothar Mayerhofer, Maarten Knechtelsdorfer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2007
Predictors of new-onset decline in kidney function in a general middle-european populationRudolf P Obermayr, Christian Temml, Maarten Knechtelsdorfer, et al.
Pageof 1